Recombinant multi-species C5/CO5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine C5/CO5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
The Alternative Names of target: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4,C5,C5D,C5a,C5b,CO5,CPAMD4,Complement C5,ECLZB,Hc,He,Hfib2,RGD1561905
Go
to C5/CO5 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T60708-Ag-1/ GM-Tg-hg-T60708-Ag-2 | Human C5/CO5 protein | Human |
| GM-Tg-rg-T60708-Ag-1/ GM-Tg-rg-T60708-Ag-2 | Rat C5/CO5 protein | Rat |
| GM-Tg-mg-T60708-Ag-1/ GM-Tg-mg-T60708-Ag-2 | Mouse C5/CO5 protein | Mouse |
| GM-Tg-cynog-T60708-Ag-1/ GM-Tg-cynog-T60708-Ag-2 | Cynomolgus/Rhesus macaque C5/CO5 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T60708-Ag-1/ GM-Tg-felg-T60708-Ag-2 | Feline C5/CO5 protein | Feline |
| GM-Tg-cang-T60708-Ag-1/ GM-Tg-cang-T60708-Ag-2 | Canine C5/CO5 protein | Canine |
| GM-Tg-bovg-T60708-Ag-1/ GM-Tg-bovg-T60708-Ag-2 | Bovine C5/CO5 protein | Bovine |
| GM-Tg-equg-T60708-Ag-1/ GM-Tg-equg-T60708-Ag-2 | Equine C5/CO5 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T60708-Ag-1/ GM-Tg-hg-T60708-Ag-2;
GM-Tg-rg-T60708-Ag-1/ GM-Tg-rg-T60708-Ag-2;
GM-Tg-mg-T60708-Ag-1/ GM-Tg-mg-T60708-Ag-2; GM-Tg-cynog-T60708-Ag-1/ GM-Tg-cynog-T60708-Ag-2; GM-Tg-felg-T60708-Ag-1/ GM-Tg-felg-T60708-Ag-2; GM-Tg-cang-T60708-Ag-1/ GM-Tg-cang-T60708-Ag-2; GM-Tg-bovg-T60708-Ag-1/ GM-Tg-bovg-T60708-Ag-2; GM-Tg-equg-T60708-Ag-1/ GM-Tg-equg-T60708-Ag-2 |
| Products Name | C5/CO5 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | C5/CO5 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine C5/CO5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.